α1-antitrypsin therapy in a case of thrombotic thrombocytopenic purpura

M. Galbusera, P. Ruggenenti, M. Noris, A. Benigni, G. Remuzzi, P. Ruggenenti, G. Remuzzi, M. Burnouf-Radosevich, P. M. Mannucci

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

In thrombotic thrombocytopenic purpura (TTP), activated leucocytes release elastase which mobilises unusually large von Willebrand factor (vWF) multimers from the endothelium. We investigated the effect of an inhibitor of leucocyte elastase (α1-antitrypsin) on circulating vWF and platelet count in a patient with chronic relapsing TTP. α1-antitrypsin consistently normalised vWF multimeric composition but failed to increase platelet count and induce remission. Plasma cryosupernatant, which never normalised vWF, always induced laboratory and clinical remission within 96 hours. In chronic relapsing TTP, unusually large vWF multimers are not the main cause of intravascular platelet aggregation.

Original languageEnglish
Pages (from-to)224-225
Number of pages2
JournalLancet
Volume345
Issue number8944
DOIs
Publication statusPublished - Jan 28 1995

Fingerprint

Thrombotic Thrombocytopenic Purpura
von Willebrand Factor
Leukocyte Elastase
Platelet Count
Therapeutics
Platelet Aggregation
Endothelium

ASJC Scopus subject areas

  • Medicine(all)

Cite this

α1-antitrypsin therapy in a case of thrombotic thrombocytopenic purpura. / Galbusera, M.; Ruggenenti, P.; Noris, M.; Benigni, A.; Remuzzi, G.; Ruggenenti, P.; Remuzzi, G.; Burnouf-Radosevich, M.; Mannucci, P. M.

In: Lancet, Vol. 345, No. 8944, 28.01.1995, p. 224-225.

Research output: Contribution to journalArticle

Galbusera, M. ; Ruggenenti, P. ; Noris, M. ; Benigni, A. ; Remuzzi, G. ; Ruggenenti, P. ; Remuzzi, G. ; Burnouf-Radosevich, M. ; Mannucci, P. M. / α1-antitrypsin therapy in a case of thrombotic thrombocytopenic purpura. In: Lancet. 1995 ; Vol. 345, No. 8944. pp. 224-225.
@article{6904152e22a14667b01d37e5297c41bb,
title = "α1-antitrypsin therapy in a case of thrombotic thrombocytopenic purpura",
abstract = "In thrombotic thrombocytopenic purpura (TTP), activated leucocytes release elastase which mobilises unusually large von Willebrand factor (vWF) multimers from the endothelium. We investigated the effect of an inhibitor of leucocyte elastase (α1-antitrypsin) on circulating vWF and platelet count in a patient with chronic relapsing TTP. α1-antitrypsin consistently normalised vWF multimeric composition but failed to increase platelet count and induce remission. Plasma cryosupernatant, which never normalised vWF, always induced laboratory and clinical remission within 96 hours. In chronic relapsing TTP, unusually large vWF multimers are not the main cause of intravascular platelet aggregation.",
author = "M. Galbusera and P. Ruggenenti and M. Noris and A. Benigni and G. Remuzzi and P. Ruggenenti and G. Remuzzi and M. Burnouf-Radosevich and Mannucci, {P. M.}",
year = "1995",
month = "1",
day = "28",
doi = "10.1016/S0140-6736(95)90224-4",
language = "English",
volume = "345",
pages = "224--225",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Lancet Publishing Group",
number = "8944",

}

TY - JOUR

T1 - α1-antitrypsin therapy in a case of thrombotic thrombocytopenic purpura

AU - Galbusera, M.

AU - Ruggenenti, P.

AU - Noris, M.

AU - Benigni, A.

AU - Remuzzi, G.

AU - Ruggenenti, P.

AU - Remuzzi, G.

AU - Burnouf-Radosevich, M.

AU - Mannucci, P. M.

PY - 1995/1/28

Y1 - 1995/1/28

N2 - In thrombotic thrombocytopenic purpura (TTP), activated leucocytes release elastase which mobilises unusually large von Willebrand factor (vWF) multimers from the endothelium. We investigated the effect of an inhibitor of leucocyte elastase (α1-antitrypsin) on circulating vWF and platelet count in a patient with chronic relapsing TTP. α1-antitrypsin consistently normalised vWF multimeric composition but failed to increase platelet count and induce remission. Plasma cryosupernatant, which never normalised vWF, always induced laboratory and clinical remission within 96 hours. In chronic relapsing TTP, unusually large vWF multimers are not the main cause of intravascular platelet aggregation.

AB - In thrombotic thrombocytopenic purpura (TTP), activated leucocytes release elastase which mobilises unusually large von Willebrand factor (vWF) multimers from the endothelium. We investigated the effect of an inhibitor of leucocyte elastase (α1-antitrypsin) on circulating vWF and platelet count in a patient with chronic relapsing TTP. α1-antitrypsin consistently normalised vWF multimeric composition but failed to increase platelet count and induce remission. Plasma cryosupernatant, which never normalised vWF, always induced laboratory and clinical remission within 96 hours. In chronic relapsing TTP, unusually large vWF multimers are not the main cause of intravascular platelet aggregation.

UR - http://www.scopus.com/inward/record.url?scp=0028950337&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028950337&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(95)90224-4

DO - 10.1016/S0140-6736(95)90224-4

M3 - Article

C2 - 7823715

AN - SCOPUS:0028950337

VL - 345

SP - 224

EP - 225

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 8944

ER -